Skip Nav Destination
Issues
1 June 2004
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1055-9965
EISSN 1538-7755
Editorials
Looking Farther Afield
Research Articles
Cell Proliferation and Apoptotic Indices Predict Adenoma Regression in a Placebo-Controlled Trial of Celecoxib in Familial Adenomatous Polyposis Patients
Frank A. Sinicrope; Elizabeth Half; Jeffrey S. Morris; Patrick M. Lynch; Jason D. Morrow; Bernard Levin; Ernest T. Hawk; Deborah S. Cohen; Gregory D. Ayers; L. Clifton Stephens; Familial Adenomatous Polyposis Study Group
Short Communications
Null Results in Brief
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.